IL1B and colitis: While there is no direct evidence for the role of IL-1β in colitis-associated colon cancer (CAC), studies have indicated that IL-1β may promote tumor growth and invasion by inducing an epithelial to mesenchymal transition (EMT) and stem cell phenotype thus increasing the invasiveness of colon cancer cells (Li et al., 2012).